IL71960A - Fused tricyclic derivatives of naphthyridinone,pyrido(2,3-b)pyrazinone and quinolone and the corresponding thiones,their preparation and pharmaceutical compositions containing them - Google Patents

Fused tricyclic derivatives of naphthyridinone,pyrido(2,3-b)pyrazinone and quinolone and the corresponding thiones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL71960A
IL71960A IL71960A IL7196084A IL71960A IL 71960 A IL71960 A IL 71960A IL 71960 A IL71960 A IL 71960A IL 7196084 A IL7196084 A IL 7196084A IL 71960 A IL71960 A IL 71960A
Authority
IL
Israel
Prior art keywords
naphthyridinone
pyrazinone
quinolone
pyrido
preparation
Prior art date
Application number
IL71960A
Other languages
English (en)
Other versions
IL71960A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL71960A0 publication Critical patent/IL71960A0/xx
Publication of IL71960A publication Critical patent/IL71960A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL71960A 1983-05-31 1984-05-29 Fused tricyclic derivatives of naphthyridinone,pyrido(2,3-b)pyrazinone and quinolone and the corresponding thiones,their preparation and pharmaceutical compositions containing them IL71960A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49958483A 1983-05-31 1983-05-31
US06/597,887 US4680298A (en) 1983-05-31 1984-04-09 Tricyclic anti-allergy and use as anti-inflammatory agents

Publications (2)

Publication Number Publication Date
IL71960A0 IL71960A0 (en) 1984-09-30
IL71960A true IL71960A (en) 1988-07-31

Family

ID=27053194

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71960A IL71960A (en) 1983-05-31 1984-05-29 Fused tricyclic derivatives of naphthyridinone,pyrido(2,3-b)pyrazinone and quinolone and the corresponding thiones,their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4680298A (fr)
EP (1) EP0127135B1 (fr)
JP (1) JPH0747590B2 (fr)
AU (1) AU559754B2 (fr)
CA (1) CA1251208A (fr)
DE (1) DE3483064D1 (fr)
DK (1) DK160557C (fr)
GB (1) GB2142013B (fr)
GR (1) GR81552B (fr)
HK (1) HK8092A (fr)
IL (1) IL71960A (fr)
NZ (1) NZ208310A (fr)
PH (1) PH22970A (fr)
SG (1) SG83890G (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
US4596809A (en) * 1985-03-25 1986-06-24 Schering Corporation Substituted 1,8-naphthyridinones, useful as anti-allergic agents
US5116840A (en) * 1985-06-13 1992-05-26 Schering Corporation Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
US4810708A (en) * 1986-05-15 1989-03-07 Schering Corporation Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
US4988705A (en) * 1985-06-13 1991-01-29 Schering Corporation Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
PT82752B (pt) 1985-06-13 1988-12-15 Schering Corp Processo para a preparacao de derivados policiclicos de quinolina, naftiridina e pirazinopiridina
WO1986007537A2 (fr) * 1985-06-18 1986-12-31 Schering Corporation Compositions pharmaceutiques contenant des azanaphtalenes
US4801589A (en) * 1986-06-12 1989-01-31 Schering Corporation Method for suppressing the immune response
FI88033C (fi) * 1986-04-11 1993-03-25 Schering Corp Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklobuta-, cyklopenta- och 7,8,9,10-tetrahydrobenso/c//1,8/naftyridin-6-onderivat
US4760073A (en) * 1986-04-11 1988-07-26 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents
US4882332A (en) * 1986-10-20 1989-11-21 Schering Corporation Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
US5045542A (en) * 1986-10-20 1991-09-03 Schering Corporation Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives
US5350755A (en) * 1986-12-05 1994-09-27 Schering Corporation Compounds and methods for treating hyperproliferative skin disease
US4740511A (en) * 1987-02-18 1988-04-26 Schering Corporation Method of treating hyperproliferative skin disease
CA1309658C (fr) * 1986-12-05 1992-11-03 David J. Blythin Compositions pharmaceutiques pour le traitement des maladies hyperproliferatives de la peau
JPH0678317B2 (ja) * 1987-07-15 1994-10-05 シェリング・コーポレーション 縮合ベンズアゼピン
US4897487A (en) * 1988-04-06 1990-01-30 Schering Corporation Process for preparing intermediates for pharmaceutically useful bicyclic compounds
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
WO1989002739A1 (fr) * 1987-10-05 1989-04-06 Pfizer Inc. Derives de 4-aminopyridine
US4859669A (en) * 1987-12-23 1989-08-22 Schering Corporation Antiinflammatory and anti-hyperproliferative naphthyridin-4-ones
US5180823A (en) * 1988-04-06 1993-01-19 Schering Corporation Processes for preparing bicyclic compounds
US5079360A (en) * 1988-04-06 1992-01-07 Schering Corporation Processes for preparing bicyclic compounds and intermediates thereof
US4996212A (en) * 1989-12-21 1991-02-26 Schering Corporation Antiinflammatory and anti-hyperproliferative compounds
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (fr) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Systeme pharma-informatique
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
EP2367821B1 (fr) * 2008-12-17 2015-09-16 Merck Patent GmbH Inhibiteurs de protéines kinases de type benzonaphtyridinones tricycliques modifiées sur le noyau c et leur utilisation
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (fr) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Compositions pour libération dermique comprenant des complexes principe actif-particule de phosphate de calcium et procédés d'utilisation associés
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN113943288A (zh) * 2020-07-17 2022-01-18 微境生物医药科技(上海)有限公司 5,6-二氢吡嗪并[2,3-c]异喹啉化合物
CN115611896A (zh) * 2021-07-16 2023-01-17 中国药科大学 含四氢萘啶酮或四氢吡啶并嘧啶酮骨架的化合物及其制备方法与制药用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB855022A (en) * 1957-08-06 1960-11-30 Geigy Ag J R Improvements in and relating to carbostyril derivatives
IT1054655B (it) * 1975-08-27 1981-11-30 Lepetit Spa Derivati condensati del l isochinolina
JPS5854152B2 (ja) * 1976-03-25 1983-12-02 久光製薬株式会社 新規なナフチリジン誘導体
EP0005745B1 (fr) * 1978-05-26 1982-07-14 Gruppo Lepetit S.P.A. Pyrazolo (3,4-c) et thiazolo (5,4-c) isoquinolines, procédé pour leur préparation, ces composés utilisables comme agent anti-inflammatoire anti-anxiété et à action sur le SNC, et compositions pharmaceutiques les contenant
NL89090C (fr) * 1978-06-05
DE3368929D1 (de) * 1982-04-26 1987-02-12 Schering Corp 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
US4452800A (en) * 1982-04-26 1984-06-05 Schering Corporation Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases

Also Published As

Publication number Publication date
CA1251208A (fr) 1989-03-14
AU559754B2 (en) 1987-03-19
PH22970A (en) 1989-02-10
GB8413582D0 (en) 1984-07-04
NZ208310A (en) 1986-11-12
EP0127135A2 (fr) 1984-12-05
DK160557C (da) 1991-09-09
GB2142013B (en) 1987-01-21
US4680298A (en) 1987-07-14
HK8092A (en) 1992-01-31
JPS6034967A (ja) 1985-02-22
IL71960A0 (en) 1984-09-30
EP0127135B1 (fr) 1990-08-29
GR81552B (fr) 1984-12-11
JPH0747590B2 (ja) 1995-05-24
EP0127135A3 (en) 1985-08-21
DK264784D0 (da) 1984-05-29
DE3483064D1 (de) 1990-10-04
SG83890G (en) 1990-11-23
DK160557B (da) 1991-03-25
DK264784A (da) 1984-12-01
GB2142013A (en) 1985-01-09
AU2882484A (en) 1984-12-06

Similar Documents

Publication Publication Date Title
IL71960A (en) Fused tricyclic derivatives of naphthyridinone,pyrido(2,3-b)pyrazinone and quinolone and the corresponding thiones,their preparation and pharmaceutical compositions containing them
IL62494A0 (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
IL64759A (en) 3-substituted 1,3-dihydro-7-hydroxy-6-methyl-furo-(3,4-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
PH17158A (en) Imidazo(1,2-a)pyridin-2-yl carbostyril derivatives and compositions containing same
IL87714A0 (en) 3,7-diazabicyclo(3,3,1)nonane derivatives,their preparation and pharmaceutical compositions containing them
IL68442A0 (en) Imidazo(1,2-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL71365A0 (en) Derivatives of indole alkaloids,their preparation and pharmaceutical compositions containing them
IL54815A (en) 5,11-dihydro-11-substitudet alkanoyl pyrido (2,3-b) (1,4) benzodiazepin-6-one derivatives their preparation and pharmaceutical compositions containing them
IL70485A (en) Imidazo(1,5-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL54813A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing
NZ218880A (en) Pyrido(2,3-b)indole-3-carboxylic acid derivatives and pharmaceutical compositions thereof
IL54814A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing tthem
IL65337A0 (en) Imidazo(1,2-a)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL59802A0 (en) Substituted pyrido (1,2-a) pyrimidines,their preparation and pharmaceutical compositions containing them
ZA855937B (en) Imidazo 1,2-a quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL66101A (en) Substituted imidazo(1,5-a)pyridines,their manufacture and pharmaceutical compositions containing them
IL51853A (en) 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
IL65977A (en) 1,4,9,10-tetrahydropyrazolo(4,3-e)pyrido(3,2-b)(1,4)diazepin-10-one derivatives,their preparation and pharmaceutical compositions containing them
IL66146A0 (en) Substituted pyrrolo(2,1-b)quinazolines and pyrido(2,1-b)quinazolines,their preparation and pharmaceutical compositions containing them
ZA877532B (en) Imidazo(4,5-b)pyridin-2-one derivatives,their preparation and compositions containing them
IL70651A (en) 7-(2-arylethenyl)-5-oxo-5h-thiazolo(3,2-a)pyrimidine-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL78164A0 (en) 5-h pyrido(3',4'-:4,5)pyrrolo(3,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL65555A (en) 5-pyridyl-1h-pyrazolo(3,4-b)pyridin-3-amine derivatives,their preparation and pharmaceutical compositions containing them
IL89098A (en) Amino- or cyclicamino-acyl substituted pyrido-(2,3-b) (1,4)-and thieno (3,4-b) (1,5) benzodiazepinones, their preparation and pharmaceutical compositions containing them
ZA862943B (en) 12b-substituted 1-hydroxymethyl-octahydroindolo-(2,3-a)quinolizine derivatives,process for their preparation and pharmaceutical compositions containing them